will depend on the study results, two transactions involving compounds to treat rheumatoid arthritis stand out, Aubery said. Eli Lilly & Co. in 2009 bought worldwide rights to an experimental pill being developed by Incyte Corp. to treat inflammatory...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Arthritis Drug���s $1.4 Billion Promise for 4SC Hinges on Study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account